[Catecholamine metabolism in different forms of Parkinson's disease].
Catecholamine metabolism was evaluated by daily urine excretion in patients with Parkinson's disease of tremor (18 patients) and rigid (14 patients) types. The group included 16 untreated patients. According to urine analysis, most informative peripheral markers for dopamine metabolism proved to be DOPA excretion, 3,4-dioxyphenylacidic acid (DOPAA) level and DOPA/DOPAA ratio. In the initial disease stage, a marked decrease of free dopamine and noradrenaline as well as dopamine metabolism intensification with corresponding DOPA/DOPAA ratio decrease were found. Significantly lower DOPAA and DOPA excretion was detected in patients with predominance of akinesia and rigidity types compared to tremor ones. In contrast to untreated patients, those treated with drugs containing dopamine revealed correlations between daily urine DOPA excretion as well as DOPA/DOPAA ratio with neurological symptoms severity.
Selikhova
M V
MV
Kogan
B M
BM
Serkin
G V
GV
Gusev
E I
EI
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism / Q000652:urine; D000368:Aged; D002395:Catecholamines / Q000378:metabolism*; D003627:Data Interpretation, Statistical; D004295:Dihydroxyphenylalanine / Q000378:metabolism / Q000652:urine; D004298:Dopamine / Q000378:metabolism / Q000652:urine; D004837:Epinephrine / Q000378:metabolism / Q000652:urine; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000378:metabolism / Q000652:urine; D010300:Parkinson Disease / Q000145:classification / Q000378:metabolism* / Q000652:urine; D012189:Retrospective Studies; D012984:Software; D013997:Time Factors
D002395:Catecholamines; D015102:3,4-Dihydroxyphenylacetic Acid; D004295:Dihydroxyphenylalanine; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine